MedTrace Logo

Vaginal Progesterone Versus Placebo in Multiple Pregnancy

NCT00343265 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2013-08-15

No results posted yet for this study

Summary

The purpose of this study is to see if daily use of vaginal progesterone will prevent preterm birth in women carrying 2 or more babies.

Conditions

Interventions

DRUG

Vaginal progesterone gel

Vaginal gel once daily

DRUG

Placebo gel

once daily

Sponsors & Collaborators

  • Calgary Health Region

    collaborator OTHER

  • Juniper Pharmaceuticals, Inc.

    collaborator INDUSTRY

  • University of Calgary

    lead OTHER

Principal Investigators

  • Stephen Wood, MD · University of Calgary

  • Sue Ross, PhD · University of Calgary

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00343265 on ClinicalTrials.gov